Your browser doesn't support javascript.
loading
Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia.
Zhang, Jingliao; Duan, Yongjuan; Wu, Peng; Chang, Yanxia; Wang, Yue; Hu, Tianyuan; Liu, Chao; Chen, Xiaoyan; Zong, Suyu; Chen, Xiaoli; Wu, Yangping; Jin, Linlin; Lan, Yang; Liu, Xiaoming; Cheng, Xuelian; Ding, Feng; Li, Tianyu; Chen, Xiaojuan; Guo, Ye; Chen, Yumei; Yang, Wenyu; Zhang, Li; Zou, Yao; Cheng, Tao; Zhu, Xiaofan; Zhang, Yingchi.
Affiliation
  • Zhang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Duan Y; Tianjin Institutes of Health Science, Tianjin, China.
  • Wu P; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Chang Y; Tianjin Institutes of Health Science, Tianjin, China.
  • Wang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Hu T; Tianjin Institutes of Health Science, Tianjin, China.
  • Liu C; Novogene Co, Ltd, Beijing, China.
  • Chen X; Novogene Co, Ltd, Beijing, China.
  • Zong S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Chen X; Tianjin Institutes of Health Science, Tianjin, China.
  • Wu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Jin L; Tianjin Institutes of Health Science, Tianjin, China.
  • Lan Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Liu X; Tianjin Institutes of Health Science, Tianjin, China.
  • Cheng X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Ding F; Tianjin Institutes of Health Science, Tianjin, China.
  • Li T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Chen X; Tianjin Institutes of Health Science, Tianjin, China.
  • Guo Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Chen Y; Tianjin Institutes of Health Science, Tianjin, China.
  • Yang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Zhang L; Tianjin Institutes of Health Science, Tianjin, China.
  • Zou Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Cheng T; Tianjin Institutes of Health Science, Tianjin, China.
  • Zhu X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Zhang Y; Tianjin Institutes of Health Science, Tianjin, China.
Blood ; 143(4): 320-335, 2024 Jan 25.
Article in En | MEDLINE | ID: mdl-37801708
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Blood Year: 2024 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Blood Year: 2024 Type: Article Affiliation country: China